KineMed has entered into a multi-year R&D collaboration GlaxoSmithKline (GSK) to develop kinetic biomarkers. The collaboration will apply KineMed's biomarker discovery platform in therapeutic areas of interest to GSK. KineMed president ...
Tags: kinetic biomarkers, GlaxoSmithKline, KineMed's technology